Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.

Fung AT, Reid SE, Jones MP, Healey PR, McCluskey PJ, Craig JC.

Br J Ophthalmol. 2007 Jan;91(1):62-8. Epub 2006 Sep 6. Review.

2.

Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension.

Orme M, Collins S, Dakin H, Kelly S, Loftus J.

Curr Med Res Opin. 2010 Mar;26(3):511-28. doi: 10.1185/03007990903498786. Review.

PMID:
20014995
4.

The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review.

Hodge WG, Lachaine J, Steffensen I, Murray C, Barnes D, Foerster V, Ducruet T, Morrison A.

Br J Ophthalmol. 2008 Jan;92(1):7-12. Review.

PMID:
18156371
5.

Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.

Katz LJ, Simmons ST, Craven ER.

Curr Med Res Opin. 2007 Dec;23(12):2971-83. Review.

PMID:
17949534
6.

A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.

Denis P, Lafuma A, Khoshnood B, Mimaud V, Berdeaux G.

Curr Med Res Opin. 2007 Mar;23(3):601-8. Review.

PMID:
17355741
7.
8.

Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.

Honrubia F, García-Sánchez J, Polo V, de la Casa JM, Soto J.

Br J Ophthalmol. 2009 Mar;93(3):316-21. doi: 10.1136/bjo.2007.135111. Epub 2008 Nov 19. Review.

9.

Efficacy and tolerability of latanoprost compared with timolol in the treatment of patients with chronic angle-closure glaucoma.

Lou H, Zong Y, Ge YR, Cheng JW, Wei RL.

Curr Med Res Opin. 2014 Jul;30(7):1367-73. doi: 10.1185/03007995.2014.905825. Epub 2014 Mar 27. Review.

PMID:
24641069
10.

Medical interventions for primary open angle glaucoma and ocular hypertension.

Vass C, Hirn C, Sycha T, Findl O, Bauer P, Schmetterer L.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003167. Review.

PMID:
17943780
14.

Interventions for normal tension glaucoma.

Sycha T, Vass C, Findl O, Bauer P, Groke I, Schmetterer L, Eichler H.

Cochrane Database Syst Rev. 2003;(4):CD002222. Review. Update in: Cochrane Database Syst Rev. 2010;(2):CD002222.

PMID:
14583947
16.

Effects of travoprost in the treatment of open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis.

Cheng JW, Xi GL, Wei RL, Cai JP, Li Y.

Curr Ther Res Clin Exp. 2009 Aug;70(4):335-50. doi: 10.1016/j.curtheres.2009.08.006. Review.

17.

Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension.

Sanford M.

Clin Drug Investig. 2014 Jul;34(7):521-8. doi: 10.1007/s40261-014-0203-4. Review.

PMID:
24895141
18.

WITHDRAWN: Interventions for normal tension glaucoma.

Sycha T, Vass C, Findl O, Bauer P, Groke I, Schmetterer L, Eichler HG.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD002222. doi: 10.1002/14651858.CD002222.pub2. Review.

PMID:
20166063
19.

A review of the use of latanoprost for glaucoma since its launch.

Digiuni M, Fogagnolo P, Rossetti L.

Expert Opin Pharmacother. 2012 Apr;13(5):723-45. doi: 10.1517/14656566.2012.662219. Epub 2012 Feb 21. Review.

PMID:
22348427
20.

Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis.

Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, Wormald R, Dickersin K.

Ophthalmology. 2016 Jan;123(1):129-40. doi: 10.1016/j.ophtha.2015.09.005. Epub 2015 Oct 31. Review.

Supplemental Content

Support Center